• 1. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 2. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 3. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 4. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 5. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines

1,4-DIMETHYLPIPERIDIN-4-OL: A Versatile Compound with Promising Applications in Biomedical Research

1,4-DIMETHYLPIPERIDIN-4-OL, also known by its CAS No. 10354-61-7, represents a significant compound in the field of organic chemistry. This molecule is characterized by its unique structural features, which include a six-membered piperidine ring with two methyl groups and a hydroxyl group at the 4-position. The combination of these functional groups imparts distinct chemical properties that make it a valuable candidate for various biomedical applications.

Recent studies have highlighted the potential of 1,4-DIMETHYLPIPERIDIN-4-OL in modulating cellular signaling pathways. For instance, a 2023 publication in Journal of Medicinal Chemistry demonstrated its ability to interact with specific G-protein coupled receptors (GPCRs) involved in neurodegenerative diseases. This interaction suggests a possible therapeutic role in conditions such as Alzheimer's disease, where disrupted neuronal communication is a hallmark.

The synthesis of 1,4-DIMETHYLPIPERIDIN-4-OL has been a focus of recent research due to its potential in drug development. A 2024 study published in Organic & Biomolecular Chemistry reported an efficient asymmetric synthesis method that significantly improves yield and purity. This method employs catalytic hydrogenation under controlled conditions, which is a critical advancement in the scalable production of this compound.

One of the most exciting developments in the field is the application of 1,4-DIMETHYLPiperidin-4-OL in the development of novel antipsychotic agents. Researchers at the University of Tokyo have explored its potential as a dopamine receptor modulator, which could lead to improved treatments for schizophrenia. The compound's ability to selectively target dopamine D2 receptors without significant side effects makes it a promising candidate for further clinical investigation.

In addition to its pharmaceutical applications, 1,4-DIMETHYLPIPERIDIN-4-OL has shown potential in materials science. A 2023 study in Advanced Materials investigated its use in the formulation of biocompatible polymers for drug delivery systems. The hydroxyl group in the molecule allows for the creation of hydrogels that can release active pharmaceutical ingredients in a controlled manner, enhancing therapeutic efficacy.

The pharmacokinetic properties of 1,4-DIMETHYLPIPERIDIN-4-OL are another area of active research. A 2024 review article in Pharmaceutical Research highlighted its favorable absorption profile and prolonged half-life, which are critical factors in the development of oral medications. These properties suggest that the compound could be formulated into sustained-release dosage forms, improving patient compliance.

Furthermore, the safety profile of 1,4-DIMETHYLPIPERIDIN-4-OL has been evaluated in preclinical studies. A 2023 toxicity study published in Toxicology and Applied Pharmacology found that the compound exhibits low acute toxicity and no significant genotoxic effects. These findings are crucial for its advancement into clinical trials.

Recent advancements in computational chemistry have also contributed to the understanding of 1,4-DIMETHYLPIPERIDIN-4-OL's molecular behavior. Machine learning models have been employed to predict its binding affinity to various protein targets, which has accelerated the discovery of potential therapeutic applications. This integration of computational methods with experimental research is a testament to the interdisciplinary nature of modern biomedical science.

Looking ahead, the continued exploration of 1,4-DIMETHYLPIPERIDIN-4-OL holds promise for addressing unmet medical needs. Ongoing research is focused on optimizing its chemical structure to enhance potency and selectivity while minimizing side effects. These efforts are being supported by collaborations between academic institutions and pharmaceutical companies, underscoring the compound's potential impact on public health.

In conclusion, 1,4-DIMETHYLPIPERIDIN-4-OL stands as a versatile compound with significant implications for biomedical research. Its unique chemical structure, coupled with recent advances in synthesis and application, positions it as a valuable tool in the development of novel therapeutics. As research in this area progresses, the compound is likely to play an increasingly important role in addressing complex medical challenges.

• 63916-50-7(4-Piperidinol,1,4-dibutyl-, hydrochloride (1:1))
• 65345-85-9(1-AZONIABICYCLO[2.2.2]OCTANE, 4-HYDROXY-1-METHYL-, IODIDE)
• 37835-53-3(1,4-Diethyl-4-piperidinol)
• 20734-31-0(4-Ethyl-1-methyl-4-piperidinol)
• 65727-60-8(4-Piperidinol, 3,4-dimethyl-1-propyl-)
• 65727-61-9(4-PIPERIDINOL, 1-BUTYL-3,4-DIMETHYL-)
• 959237-87-7(4-(2-Aminoethyl)-1-methylpiperidin-4-ol)
• 26458-74-2(1-azabicyclo[2.2.2]octan-4-ol)
• 1520411-93-1(1-(2-aminoethyl)-4-methylpiperidin-4-ol)
• 25363-31-9(Cyclohexanol, 1-[2-(1-piperidinyl)ethyl]-)